Related content

The prevalence of metabolic syndrome in clomiphene citrate resistant polycystic ovary syndrome

By Verit Fatma Ferda  

Gynecological Endocrinology, Vol. 28, Iss. 5, 2012-05 ,pp. : 365-369

Informa Healthcare

Access to resources Recommend Favorite

Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study

By Elnashar Aboubakr   Abdelmageed Emad   Fayed Mahmod   Sharaf Magdy  

Human Reproduction, Vol. 21, Iss. 7, 2006-07 ,pp. : 1805-1808

Oxford University Press

Access to resources Recommend Favorite

Endometrial biopsy during induction of ovulation with clomiphene citrate in polycystic ovary syndrome

By Homburg Roy   Pap Hannah   Brandes Monique   Huirne Judith   Hompes Peter   Lambalk Cornelius B.  

Gynecological Endocrinology, Vol. 22, Iss. 9, 2006-09 ,pp. : 506-510

Informa Healthcare

Access to resources Recommend Favorite

Sequential treatment of metformin and clomiphene citrate in clomiphene‐resistant women with polycystic ovary syndrome: a randomized, controlled trial

By George Susan Shanti  

Human Reproduction, Vol. 18, Iss. 2, 2003-02 ,pp. : 299-304

Oxford University Press

Access to resources Recommend Favorite

A randomized controlled trial of the effect of rosiglitazone and clomiphene citrate versus clomiphene citrate alone in overweight/obese women with polycystic ovary syndrome

By Mohsen Iman Abdel  

Gynecological Endocrinology, Vol. 28, Iss. 4, 2012-04 ,pp. : 269-272

Informa Healthcare

Access to resources Recommend Favorite